Compare PLAY & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLAY | EBS |
|---|---|---|
| Founded | 1982 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.3M | 413.3M |
| IPO Year | 2011 | 2006 |
| Metric | PLAY | EBS |
|---|---|---|
| Price | $10.17 | $4.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $23.83 | $12.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 06-09-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | ★ 0.16 | N/A |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | $5.57 | $1.29 |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | $66.44 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.40 | $4.36 |
| 52 Week High | $26.29 | $14.06 |
| Indicator | PLAY | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 46.20 | 21.31 |
| Support Level | $9.50 | N/A |
| Resistance Level | $10.85 | $8.73 |
| Average True Range (ATR) | 0.59 | 0.33 |
| MACD | 0.02 | -0.25 |
| Stochastic Oscillator | 16.06 | 7.49 |
Dave & Buster's Entertainment Inc is an owner and operator of entertainment and dining venues in North America that offer experiences for both adults and families under the Dave & Buster's and Main Event brands. The company combines various forms of entertainment, including games, bowling, and watching live sports and other televised events, with a full menu of entrees and appetizers and a selection of alcoholic and non alcoholic beverages, all in one location. Its concept focuses on providing customers the opportunity to Eat, Drink, Play, and Watch, appealing to a balanced mix of adults, families, and teenagers. The company also operates internationally in the early stage as a franchisor of the Dave & Buster's brand.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.